Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.

[1]  D E Low,et al.  Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus , 1992, Journal of clinical microbiology.

[2]  M. Kelly,et al.  Comparison of three automated systems for antimicrobial susceptibility testing of gram-negative bacilli , 1982, Journal of clinical microbiology.

[3]  Derek F. J. Brown,et al.  Evaluation of the E test, a novel method of quantifying antimicrobial activity. , 1991, The Journal of antimicrobial chemotherapy.

[4]  J. Tokars,et al.  Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci , 1993 .

[5]  C Thornsberry,et al.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria , 1991, Journal of clinical microbiology.

[6]  R. Sykes,et al.  Aztreonam: the first monobactam. , 1985, The American journal of medicine.

[7]  C. Stratton,et al.  Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems. , 1992, Diagnostic microbiology and infectious disease.

[8]  D. Low,et al.  Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1 , 1993, Journal of clinical microbiology.

[9]  D E Low,et al.  Detection of vancomycin resistance in Enterococcus species , 1992, Journal of clinical microbiology.

[10]  L. Gerckens,et al.  Antibacterial activity of imipenem: the first thienamycin antibiotic. , 1985, Reviews of infectious diseases.